Molluscum contagiosum

DEADLINE ALERT for ET, APYX, VRCA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Thursday, July 21, 2022
Transfer, Time, Investment, Tuscarawas, GLOBE, Class, Law, Telephone, Energy, People's Law Office, NDA, Molluscum contagiosum, FERC, Company, HDD, LLC, Suite, Security (finance), Risk management

BENSALEM, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Digital Turbine, Inc. (APPS), Teladoc Health, Inc. (TDOC), and Verrica Pharmaceuticals, Inc. (VRCA) and Encourages Invest

Retrieved on: 
Thursday, July 21, 2022
Inc., GLOBE, Court, Digital, NDA, Kirby, Molluscum contagiosum, Defendant, Lists of schools in England, Teladoc Health, Growth, EBITDA, Pharmaceutical industry, Online shopping

Additional information about each case can be found at the links provided below.

Key Points: 
  • Additional information about each case can be found at the links provided below.
  • Kirby McInerney is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teladoc, Verrica, Apyx, and Waste Management and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 21, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Negotiation, New Drug Application, News, Company, Lists of schools in England, Waste Management (corporation), Teladoc Health, LLC, SMR, EBITDA, Acquisition, Tripura Merger Agreement, Walmart, Prospectus, Molluscum contagiosum, Defendant, DOJ, Growth, Office of Inspector General, U.S. Department of Health and Human Services, Waste management, GLOBE, Industry, Food, Disclosure, CMO, Failure, U.S. Department of Justice Office of Legislative Affairs, Endpoint security, D2C, Mergers and acquisitions, FDA, Amazon (company), Tax, GFL Environmental, BetterHelp, Advanced Energy, Energy Products Inc, NYSE, NDA, NASDAQ, Mental health, P.C, Coagulation, TDOC, Depreciation, Risk management, Pharmaceutical industry, Audit, Animal, Bank, Note

Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.

Key Points: 
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • In the Notes prospectus, Waste Management represented that the Merger would close by the first quarter of 2020.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

DEADLINE ALERT for APYX, VRCA, APPS, and TDOC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, July 19, 2022
Law, Investment, Time, GLOBE, Molluscum contagiosum, Twitter, Complaint, Lists of schools in England, Defendant, Teladoc Health, Suite, Company, NDA, Growth, EBITDA, Mail, Risk management, Pharmaceutical industry

LOS ANGELES, July 19, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, July 19, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

Novan Satisfies $16.5 Million Outstanding Promissory Note

Retrieved on: 
Tuesday, July 19, 2022
Leadership, Acquisition, Novin, Hand, Patient, Security (finance), Skin, Rosacea, U.S. Securities and Exchange Commission, Safety, Annual report, GLOBE, Private Securities Litigation Reform Act, Forward-looking statement, Health, EPG, LLC, SB206, Marketing, Psoriasis, Acne, COVID-19, Company, NDA, Risk, Molluscum contagiosum, Pharmacy, EPI, FDA, Bank, Pharmaceutical industry

DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it had reached agreement with Evening Post Group, LLC (“EPG”) regarding payment, satisfaction and termination of its secured promissory note and security agreement associated with the March 11, 2022 acquisition of EPI Health. Novan and EPG agreed that, upon EPG’s receipt of $10.0 million, which Novan subsequently paid, all outstanding indebtedness and obligations of Novan under the promissory note are fully satisfied, and accordingly, the promissory note and related security agreements are terminated.

Key Points: 
  • Novan and EPG agreed that, upon EPGs receipt of $10.0 million, which Novan subsequently paid, all outstanding indebtedness and obligations of Novan under the promissory note are fully satisfied, and accordingly, the promissory note and related security agreements are terminated.
  • Using cash generated through the sales of its commercial products, as well as existing cash on hand (other than from the proceeds from Novans June 2022 registered direct offering), Novan has paid EPG in full satisfaction of all outstanding indebtedness and obligations under the promissory note.
  • The liens on the membership interests and assets of EPI Health, which had previously secured the promissory note, were terminated, and no obligations related to the securities agreement remain outstanding.
  • Novan, Inc. is a medical dermatology company primarily focused on researching, developing, and commercializing innovative therapeutic products for skin diseases.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Retrieved on: 
Monday, July 18, 2022
News, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Time, CMO, GLOBE, Food, Endpoint security, Molluscum contagiosum, Lists of schools in England, New Drug Application, LLC, GPM, NASDAQ, Suite, NDA, Court, VP, Defendant, Pharmaceutical industry, Animal, Risk management

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • In December 2020, Verrica submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking regulatory approval of VP-102 for the treatment of molluscum.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

APYX, APPS & VRCA Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

Retrieved on: 
Monday, July 18, 2022
GLOBE, Complaint, Court, Molluscum contagiosum, Lists of schools in England, Company, LLC, NDA, Defendant, Risk management, Pharmaceutical industry

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • That Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

Retrieved on: 
Sunday, July 17, 2022
News, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LLP, CMO, GLOBE, Food, Molluscum contagiosum, Endpoint security, New Drug Application, LLC, NASDAQ, Company, NDA, Pomerantz, VP, Pharmaceutical industry

NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals, Inc. (Verrica or the Company) (NASDAQ:VRCA).

Key Points: 
  • NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals, Inc. (Verrica or the Company) (NASDAQ:VRCA).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Verrica and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Verrica, Apyx, Waste Management, and Tupperware and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 16, 2022
News, Coagulation, Acquisition, Energy Products Inc, Tripura Merger Agreement, Waste management, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Advanced Energy, Waste Management (corporation), Prospectus, Disclosure, CMO, DOJ, Mergers and acquisitions, Food, Failure, GLOBE, NYSE, Endpoint security, Molluscum contagiosum, Lists of schools in England, Negotiation, New Drug Application, SMR, U.S. Department of Justice Office of Legislative Affairs, LLC, NASDAQ, Company, NDA, GFL Environmental, Tupperware, Office of Inspector General, U.S. Department of Health and Human Services, FDA, Defendant, Tupperware Brands, Pharmaceutical industry, Animal, Renewable energy, Risk management, Audit, Bank, P.C, Note

In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.

Key Points: 
  • In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    On May 4, 2022, Tupperware announced its financial results for the first quarter of 2022.
  • For more information on the Tupperware class action go to: https://bespc.com/cases/TUP
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action – VRCA

Retrieved on: 
Saturday, July 16, 2022
Titan, Advertising, WHY, Facebook, THE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LinkedIn, I-Space (Chinese company), Cantharidin, Food, Molluscum contagiosum, Twitter, Lists of schools in England, New Drug Application, NASDAQ, Class, TO, Court, Security (finance), Insurance, Tobacco

WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.